These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28166609)

  • 1. Modulating immunogenicity of factor IX by fusion to an immunoglobulin Fc domain: a study using a hemophilia B mouse model.
    Levin D; Lagassé HA; Burch E; Strome S; Tan S; Jiang H; Sauna ZE; Golding B
    J Thromb Haemost; 2017 Apr; 15(4):721-734. PubMed ID: 28166609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential limits of AAV-based gene therapy with the use of new transgenes expressing factor IX fusion proteins.
    Le Quellec S; Dane A; Enjolras N; McIntosh J; Rosales C; Negrier C; Nathwani A
    Haemophilia; 2019 Jan; 25(1):e11-e18. PubMed ID: 30520547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer.
    Cohn EF; Zhuo J; Kelly ME; Chao HJ
    J Thromb Haemost; 2007 Jun; 5(6):1227-36. PubMed ID: 17362228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to human factor IX in haemophilia B mice of different genetic backgrounds are distinct and modified by TLR4.
    Sack BK; Wang X; Sherman A; Rogers GL; Markusic DM
    Haemophilia; 2015 Jan; 21(1):133-9. PubMed ID: 25417755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation of rAAV2/hFIX and experimentally application to gene therapy for hemophilia B].
    Peng JQ; Dong XY; Peng M; Chen L; Tan SP; Yuan H; Chen FP; Xue JL; Wu XB
    Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):513-8. PubMed ID: 15569526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Adeno-Associated Viral Vectors Expressing Human Coagulation FIX-E456H Variant in Hemophilia B Mice.
    Le Quellec S; Dane AP; Barbon E; Bordet JC; Mingozzi F; Dargaud Y; Marais T; Biferi MG; Négrier C; Nathawani AC; Enjolras N
    Thromb Haemost; 2019 Dec; 119(12):1956-1967. PubMed ID: 31659733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplacental delivery of factor IX Fc-fusion protein ameliorates bleeding phenotype of newborn hemophilia B mice.
    Sakurai F; Iizuka S; Tsukamoto T; Shiota A; Shimizu K; Ohashi K; Mizuguchi H
    J Control Release; 2024 Oct; 374():415-424. PubMed ID: 39181162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice.
    Toby GG; Liu T; Buyue Y; Zhang X; Bitonti AJ; Pierce GF; Sommer JM; Jiang H; Peters RT
    PLoS One; 2016; 11(2):e0148255. PubMed ID: 26840952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete and sustained phenotypic correction of hemophilia B in mice following hepatic gene transfer of a high-expressing human factor IX plasmid.
    Ye X; Loeb KR; Stafford DW; Thompson AR; Miao CH
    J Thromb Haemost; 2003 Jan; 1(1):103-11. PubMed ID: 12871546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells.
    Liao G; Nayak S; Regueiro JR; Berger SB; Detre C; Romero X; de Waal Malefyt R; Chatila TA; Herzog RW; Terhorst C
    Int Immunol; 2010 Apr; 22(4):259-70. PubMed ID: 20139172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal gene transfer with a retroviral vector results in tolerance to human factor IX in mice and dogs.
    Zhang J; Xu L; Haskins ME; Parker Ponder K
    Blood; 2004 Jan; 103(1):143-51. PubMed ID: 12969967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo.
    Miao CH; Thompson AR; Loeb K; Ye X
    Mol Ther; 2001 Jun; 3(6):947-57. PubMed ID: 11407909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerogenic properties of the Fc portion of IgG and its relevance to the treatment and management of hemophilia.
    Blumberg RS; Lillicrap D;
    Blood; 2018 May; 131(20):2205-2214. PubMed ID: 29588277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized human factor IX expression cassettes for hepatic-directed gene therapy of hemophilia B.
    Zhang R; Wang Q; Zhang L; Chen S
    Front Med; 2015 Mar; 9(1):90-9. PubMed ID: 25663062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for hemophilia B mice with scAAV8-LP1-hFIX.
    Lu W; Zhou Q; Yang H; Wang H; Gu Y; Shen Q; Xue J; Dong X; Chen J
    Front Med; 2016 Jun; 10(2):212-8. PubMed ID: 27052253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients.
    Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL
    Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia B.
    Brown HC; Doering CB; Herzog RW; Ling C; Markusic DM; Spencer HT; Srivastava A; Srivastava A
    Hum Gene Ther; 2020 Oct; 31(19-20):1114-1123. PubMed ID: 32657150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX.
    Sun J; Hakobyan N; Valentino LA; Feldman BL; Samulski RJ; Monahan PE
    Blood; 2008 Dec; 112(12):4532-41. PubMed ID: 18716130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Human coagulation factor IX gene therapy in murine hemophilia B by hydrodynamic delivery and site-specific genomic integration].
    Zhang L; Gu DS; DU WT; Liu PX; Lu SH; Yang RC
    Zhonghua Xue Ye Xue Za Zhi; 2010 May; 31(5):294-9. PubMed ID: 21122306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained delivery of therapeutic concentrations of human clotting factor IX--a comparison of adenoviral and AAV vectors administered in utero.
    Schneider H; Mühle C; Douar AM; Waddington S; Jiang QJ; von der Mark K; Coutelle C; Rascher W
    J Gene Med; 2002; 4(1):46-53. PubMed ID: 11828387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.